NSEAnalysts/Institutional Investor Meet/Con. Call Updates21 Oct 2026 · 21 Oct 2026, 12:07 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Sudeep Pharma Limited · SUDEEPPHRM

✦ AI SummaryResults

Sudeep Pharma Limited has scheduled an earnings call with analysts and investors on October 29, 2026, to discuss its Q2 and H1FY27 results.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sudeep Pharma Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

SUDEEPPHARMALIMITED_21102026120643_Intimation_for_Earnings_Call.pdf

pdf

Download →
View document text
Date: 21st October 2026 National Stock Exchange of India Limited BSE Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Bandra Kurla Dalal Street, Mumbai – 400001 Complex, Bandra (E), Mumbai – 400051 Scrip Code: 544619 Scrip Symbol- SUDEEPPHRM Sub: Intimation of Earnings Call with Analysts/Investors on 29th October 2026 Ref: Regulation 30 of the SEBI Listing Regulations, 2015 Dear Sir/Ma’am, This is to inform that the “Earnings Call” of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter and half year ended on 30th September 2026, is scheduled as below: Day & Date: Thursday, 29th October 2026 Time: 12:00 noon. Registration Link and Access numbers: As per Annexure Copy of Earnings Call invite is annexed herewith and is also hosted on our website https://www.sudeeppharma.com/investor-relations/financial-results/#concall-invitation Kindly take the same on record. Thanking You. For Sudeep Pharma Limited Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184 ENCL: A/a CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeeppharma.com, Email ID: mail@sudeepgroup.com CONCALL INVITE 360 ONE CM Research shall hold a Conference Call of Sudeep Pharma Limited to discuss the Q2 & H1FY27 Results on Thursday, 29th October 2026 at 12:00 Hrs IST The Management Team will be represented by: Mr. Sujit Bhayani – Managing Director Mr. Shanil Bhayani – Director Mr. Ketan Vyas – Chief Financial Officer You are cordially invited Diamond Pass Link https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=0914184&linkSecuritySt ring=80396a198 Universal Dial-in Numbers +91 22 6280 1222 / +91 22 7115 8123 International Toll Free: Argentina: 0080014243444 | Australia: 0080014243444 | Belgium: 0080014243444 | Canada: 01180014243444 China: 4008428405 | France: 0800914745 | Germany: 0080014243444 | Hong Kong: 800964448 Italy: 0080014243444 | Japan: 00531161110 | Netherlands: 08000229808 | Poland: 008001124248 Singapore: 8001012045 | South Korea: 00180014243444 | Sweden: 0080014243444 Thailand: 00180014243444 | UK: 08081011573 | USA: 18667462133 For further information, please contact Mr. Rohit Nagraj 360 ONE Capital Market Research +91-22-4031 7127 rohit.nagraj@360.one